vs
Side-by-side financial comparison of Monolithic Power Systems (MPWR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $751.2M, roughly 1.5× Monolithic Power Systems). Monolithic Power Systems runs the higher net margin — 22.9% vs -127.8%, a 150.7% gap on every dollar of revenue. On growth, Monolithic Power Systems posted the faster year-over-year revenue change (20.8% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $63.9M). Over the past eight quarters, Monolithic Power Systems's revenue compounded faster (28.1% CAGR vs 1.3%).
Monolithic Power Systems, Inc. is an American, publicly traded company headquartered in Kirkland, Washington. It operates in more than 15 locations worldwide.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
MPWR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $751.2M | $1.1B |
| Net Profit | $171.7M | $-1.4B |
| Gross Margin | 55.2% | 32.6% |
| Operating Margin | 26.6% | -116.0% |
| Net Margin | 22.9% | -127.8% |
| Revenue YoY | 20.8% | -2.5% |
| Net Profit YoY | -86.3% | -3093.9% |
| EPS (diluted) | $3.50 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $751.2M | $1.1B | ||
| Q3 25 | $737.2M | $1.0B | ||
| Q2 25 | $664.6M | $1.1B | ||
| Q1 25 | $637.6M | $1.0B | ||
| Q4 24 | $621.7M | $1.1B | ||
| Q3 24 | $620.1M | $1.1B | ||
| Q2 24 | $507.4M | $1.1B | ||
| Q1 24 | $457.9M | $1.1B |
| Q4 25 | $171.7M | $-1.4B | ||
| Q3 25 | $179.8M | $7.5M | ||
| Q2 25 | $135.0M | $-8.4M | ||
| Q1 25 | $135.1M | $-6.4M | ||
| Q4 24 | $1.3B | $-44.4M | ||
| Q3 24 | $144.4M | $-21.0M | ||
| Q2 24 | $100.4M | $-108.4M | ||
| Q1 24 | $92.5M | $2.0M |
| Q4 25 | 55.2% | 32.6% | ||
| Q3 25 | 55.1% | 36.1% | ||
| Q2 25 | 55.1% | 34.4% | ||
| Q1 25 | 55.4% | 37.6% | ||
| Q4 24 | 55.4% | 33.9% | ||
| Q3 24 | 55.4% | 37.2% | ||
| Q2 24 | 55.3% | 37.0% | ||
| Q1 24 | 55.1% | 33.1% |
| Q4 25 | 26.6% | -116.0% | ||
| Q3 25 | 26.5% | 7.0% | ||
| Q2 25 | 24.8% | 4.3% | ||
| Q1 25 | 26.5% | 4.5% | ||
| Q4 24 | 26.3% | 10.0% | ||
| Q3 24 | 26.5% | 7.4% | ||
| Q2 24 | 23.0% | -2.5% | ||
| Q1 24 | 20.9% | -5.1% |
| Q4 25 | 22.9% | -127.8% | ||
| Q3 25 | 24.4% | 0.7% | ||
| Q2 25 | 20.3% | -0.8% | ||
| Q1 25 | 21.2% | -0.6% | ||
| Q4 24 | 201.8% | -3.9% | ||
| Q3 24 | 23.3% | -1.9% | ||
| Q2 24 | 19.8% | -10.2% | ||
| Q1 24 | 20.2% | 0.2% |
| Q4 25 | $3.50 | $-10.23 | ||
| Q3 25 | $3.74 | $0.05 | ||
| Q2 25 | $2.81 | $-0.06 | ||
| Q1 25 | $2.81 | $-0.05 | ||
| Q4 24 | $25.71 | $-0.32 | ||
| Q3 24 | $2.95 | $-0.15 | ||
| Q2 24 | $2.05 | $-0.79 | ||
| Q1 24 | $1.89 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.5B | $2.9B |
| Total Assets | $4.2B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $432.1M | ||
| Q2 25 | $1.1B | $454.2M | ||
| Q1 25 | $1.0B | $409.9M | ||
| Q4 24 | $862.9M | $558.8M | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.3B | $542.8M | ||
| Q1 24 | $1.3B | $658.5M |
| Q4 25 | $3.5B | $2.9B | ||
| Q3 25 | $3.4B | $4.4B | ||
| Q2 25 | $3.2B | $4.5B | ||
| Q1 25 | $3.1B | $4.4B | ||
| Q4 24 | $3.0B | $4.3B | ||
| Q3 24 | $2.4B | $4.6B | ||
| Q2 24 | $2.2B | $4.5B | ||
| Q1 24 | $2.1B | $4.7B |
| Q4 25 | $4.2B | $8.5B | ||
| Q3 25 | $4.1B | $10.1B | ||
| Q2 25 | $3.9B | $10.1B | ||
| Q1 25 | $3.7B | $9.8B | ||
| Q4 24 | $3.5B | $9.6B | ||
| Q3 24 | $2.9B | $11.2B | ||
| Q2 24 | $2.6B | $10.4B | ||
| Q1 24 | $2.6B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $104.9M | $175.4M |
| Free Cash FlowOCF − Capex | $63.9M | $148.6M |
| FCF MarginFCF / Revenue | 8.5% | 13.4% |
| Capex IntensityCapex / Revenue | 5.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.61× | — |
| TTM Free Cash FlowTrailing 4 quarters | $666.2M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.9M | $175.4M | ||
| Q3 25 | $239.3M | $51.7M | ||
| Q2 25 | $237.6M | $75.9M | ||
| Q1 25 | $256.4M | $-64.5M | ||
| Q4 24 | $167.7M | $312.6M | ||
| Q3 24 | $231.7M | $42.2M | ||
| Q2 24 | $141.0M | $9.5M | ||
| Q1 24 | $248.1M | $-1.4M |
| Q4 25 | $63.9M | $148.6M | ||
| Q3 25 | $196.8M | $29.8M | ||
| Q2 25 | $189.5M | $56.7M | ||
| Q1 25 | $216.0M | $-90.0M | ||
| Q4 24 | $102.9M | $274.9M | ||
| Q3 24 | $197.9M | $15.1M | ||
| Q2 24 | $109.5M | $-18.9M | ||
| Q1 24 | $232.1M | $-26.5M |
| Q4 25 | 8.5% | 13.4% | ||
| Q3 25 | 26.7% | 2.9% | ||
| Q2 25 | 28.5% | 5.4% | ||
| Q1 25 | 33.9% | -8.6% | ||
| Q4 24 | 16.5% | 24.2% | ||
| Q3 24 | 31.9% | 1.4% | ||
| Q2 24 | 21.6% | -1.8% | ||
| Q1 24 | 50.7% | -2.4% |
| Q4 25 | 5.5% | 2.4% | ||
| Q3 25 | 5.8% | 2.1% | ||
| Q2 25 | 7.2% | 1.8% | ||
| Q1 25 | 6.3% | 2.4% | ||
| Q4 24 | 10.4% | 3.3% | ||
| Q3 24 | 5.5% | 2.5% | ||
| Q2 24 | 6.2% | 2.7% | ||
| Q1 24 | 3.5% | 2.3% |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 1.33× | 6.89× | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 2.68× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MPWR
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
